Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Auli Verkkoniemi-Ahola

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Brain and Behavior|February 20, 2024
Plasma antioxidant potential measured by total radical trapping antioxidant parameter in a cohort of multiple sclerosis patientsMarge Kartau, Joonas Kartau, Marjatta Pohja, et al.
Degenerative Neurological and Neuromuscular Disease|December 11, 2019
Progressive Multifocal Leukoencephalopathy: Current InsightsMarge Kartau, Jussi Ot Sipilä, Eeva Auvinen, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 9, 2021
JC polyomavirus DNA detection in clinical practiceMarge Kartau, Eeva Auvinen, Auli Verkkoniemi-Ahola, et al.
Multiple Sclerosis and Related Disorders|July 22, 2015
Association between soluble L-selectin and anti-JCV antibodies in natalizumab-treated relapsing-remitting MS patientsPabitra Basnyat, Sanna Hagman, Marcin Kolasa, et al.
Open Forum Infectious Diseases|March 1, 2019
The Incidence and Predisposing Factors of John Cunningham Virus-Induced Progressive Multifocal Leukoencephalopathy in Southern Finland: A Population-Based StudyMarge Kartau, Auli Verkkoniemi-Ahola, Anders Paetau, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|October 9, 2023
Real-world treatment outcomes and safety of natalizumab in Finnish multiple sclerosis patientsAuli Verkkoniemi-Ahola, Päivi Hartikainen, Katja Hassi, et al.
Journal of Alzheimer'S Disease : JAD|December 6, 2013
Aβ38 in the brains of patients with sporadic and familial Alzheimer's disease and transgenic mouse modelsJochim Reinert, Henrik Martens, Melanie Huettenrauch, et al.
Neurobiology of Aging|October 2, 2013
Familial frontotemporal dementia associated with C9orf72 repeat expansion and dysplastic gangliocytomaRaffaele Ferrari, Mia Kero, Kin Mok, et al.
Molecular Neurodegeneration|April 4, 2014
Abundance of Aβ₅-x like immunoreactivity in transgenic 5XFAD, APP/PS1KI and 3xTG mice, sporadic and familial Alzheimer's diseaseErika Avendaño Guzmán, Yvonne Bouter, Bernhard C Richard, et al.
Duodecim; Laaketieteellinen Aikakauskirja|August 5, 2015
[Phenotype and incidence of Creutzfeldt-Jakob disease in Finland in 1997-2013]Juuso Isotalo, Maria Gardberg, Auli Verkkoniemi-Ahola, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Brain and Behavior|February 20, 2024
Plasma antioxidant potential measured by total radical trapping antioxidant parameter in a cohort of multiple sclerosis patientsMarge Kartau, Joonas Kartau, Marjatta Pohja, et al.
Degenerative Neurological and Neuromuscular Disease|December 11, 2019
Progressive Multifocal Leukoencephalopathy: Current InsightsMarge Kartau, Jussi Ot Sipilä, Eeva Auvinen, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 9, 2021
JC polyomavirus DNA detection in clinical practiceMarge Kartau, Eeva Auvinen, Auli Verkkoniemi-Ahola, et al.
Multiple Sclerosis and Related Disorders|July 22, 2015
Association between soluble L-selectin and anti-JCV antibodies in natalizumab-treated relapsing-remitting MS patientsPabitra Basnyat, Sanna Hagman, Marcin Kolasa, et al.
Open Forum Infectious Diseases|March 1, 2019
The Incidence and Predisposing Factors of John Cunningham Virus-Induced Progressive Multifocal Leukoencephalopathy in Southern Finland: A Population-Based StudyMarge Kartau, Auli Verkkoniemi-Ahola, Anders Paetau, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|October 9, 2023
Real-world treatment outcomes and safety of natalizumab in Finnish multiple sclerosis patientsAuli Verkkoniemi-Ahola, Päivi Hartikainen, Katja Hassi, et al.
Journal of Alzheimer'S Disease : JAD|December 6, 2013
Aβ38 in the brains of patients with sporadic and familial Alzheimer's disease and transgenic mouse modelsJochim Reinert, Henrik Martens, Melanie Huettenrauch, et al.
Neurobiology of Aging|October 2, 2013
Familial frontotemporal dementia associated with C9orf72 repeat expansion and dysplastic gangliocytomaRaffaele Ferrari, Mia Kero, Kin Mok, et al.
Molecular Neurodegeneration|April 4, 2014
Abundance of Aβ₅-x like immunoreactivity in transgenic 5XFAD, APP/PS1KI and 3xTG mice, sporadic and familial Alzheimer's diseaseErika Avendaño Guzmán, Yvonne Bouter, Bernhard C Richard, et al.
Duodecim; Laaketieteellinen Aikakauskirja|August 5, 2015
[Phenotype and incidence of Creutzfeldt-Jakob disease in Finland in 1997-2013]Juuso Isotalo, Maria Gardberg, Auli Verkkoniemi-Ahola, et al.
Pageof 2